Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan · Delayed Price · Currency is TWD 193.00
-5.50 (-2.77%)
May 15, 2026, 1:30 PM CST
Lotus Pharmaceutical Market Cap
Lotus Pharmaceutical has a market cap or net worth of 52.17 billion as of May 15, 2026. Its market cap has decreased by -7.87% in one year.
Market Cap
52.17B
Enterprise Value
93.98B
Revenue
24.42B
Ranking
n/a
PE Ratio
13.44
Stock Price
193.00
Market Cap Chart
Since August 12, 2014, Lotus Pharmaceutical's market cap has increased from 9.19B to 52.17B, an increase of 467.82%. That is a compound annual growth rate of 15.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 54.01B | -27.43% |
| Dec 31, 2025 | 74.42B | 4.05% |
| Dec 31, 2024 | 71.52B | -0.57% |
| Dec 29, 2023 | 71.94B | 11.59% |
| Dec 30, 2022 | 64.46B | 152.11% |
| Dec 30, 2021 | 25.57B | 30.27% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PharmaEssentia | 290.25B |
| Bora Pharmaceuticals | 51.18B |
| Center Laboratories | 28.59B |
| TTY Biopharm Company | 18.80B |
| Grape King Bio | 16.07B |
| Synmosa Biopharma | 15.51B |
| ScinoPharm Taiwan | 15.18B |
| YungShin Global Holding | 14.92B |